S H Kelkar And Company Ltd · NSE:SHK
S H Kelkar And — Q1 FY2022 Earnings Presentation
25 slides from S H Kelkar And's earnings presentation, Aug 6, 2021
Slide 1: Cover letter to stock exchanges
Keva August 06, 2021 To To The Manager The Manager The Department of Corporate Services The Listing Department BSE Limited National Stock Exchange of India Limited Floor 25, P. J. Towers, Exchange Plaza, Bandra Kurla Complex, Dalal Street, Mumbai — 400 001 Bandra (East), Mumbai — 400 051 Scrip Code:
Slide 2: S H Kelkar announces Q1 FY2022 results
S H Kelkar and Company Limited Corporate Office: L.B.S Marg, Near Balrajeshwar Temple, Mulund (W), Mumbai – 400080 Registered Office: Devkaran Mansion, 36, Mangaldas Road, Mumbai 400 002. S H Kelkar announces Q1 FY2022 results Q1 FY2022* Revenues from operations at Rs. 354.9 cr, up 85.4% EBITDA impr
Slide 3: Commenting on the performance, Mr. Kedar Vaze
Commenting on the performance, Mr. Kedar Vaze, Whole Time Director and Group CEO at SH Kelkar and Company said, “We have reported a resilient performance during the quarter despite a challenging macro- environment owing to pandemic-induced lockdowns and restrictions. While we saw broader operating c
Slide 4: Update on ITAT order
Update on ITAT order In respect of the tax appeal in the matter of Keva Fragrances, wholly owned subsidiary of SHK, the Income Tax Appellate Tribunal (ITAT), vide its order dated August 2, 2021 has set aside the order of the Commissioner of Income Tax and has directed the Assessing Officer to allo
Slide 5: About S H Kelkar and Company Limited
the employee base is fully inoculated. In addition, SHK also extended the vaccination drives for employees' families & secondary manpower. Given the second wave of the COVID-19 pandemic, SHK is undertaking all precautionary measures to mitigate business risks and ensure safety of all its stakehold
Slide 6: suitable for the recipient’s purposes. The delivery of this press release does not imply
suitable for the recipient’s purposes. The delivery of this press release does not imply that the information herein is correct as at any time subsequent to the date hereof and SHK has no obligation whatsoever to update any of the information or the conclusions contained herein or to correct any ina
Slide 7: S H Kelkar and Company Limited Q1 FY22
S H KELKAR AND COMPANY LIMITED Q1 FY22 Earnings Presentation August 6, 2021
Slide 8: Disclaimer
Disclaimer Certain statements and opinions with respect to the anticipated future performance of SH Kelkar (SHK) in the presentation (“forward-looking statements”), which reflect various assumptions concerning the strategies, objectives and anticipated results may or may not prove to be correct. Suc
Slide 9: Q1 FY22 Results Overview
aAng DUNUSIDS Q1 FY22 Results Overview
Slide 10: Management Comment
Management Comment Commenting on the performance, Mr. Kedar Vaze, Whole Time Director & CEO at SH Kelkar and Company Ltd. said: “We have reported a resilient performance during the quarter despite a challenging macro-environment owing to pandemic-induced lockdowns and restrictions. While we saw broa
Slide 11: Consolidated Summarized P&L Statement
Consolidated Summarized P&L Statement Particulars (Rs. crore) Q1 FY22 Q1 FY21 Y-o-Y Change (%) Revenue from Operations 354.9 191.4 85.4% Sales 331.9 191.4 73.4% Sales - Contract Manufacturing 23.0 - - Other Operating Income 0.6 1.1 -44.5% Total Operating Income 355.5 192.5 84.7% Other Income 3.5 4.1
Slide 12: Key Developments
Key Developments The Board of Directors appoint Mr. Rohit Saraogi as Executive Vice President & Group CFO (designate) of Company Mr. Shrikant Mate, Executive Vice President & Group CFO, will be superannuating on September 30, 2021 Mr. Saraogi has been appointed as Executive Vice President & Grou
Slide 13: Key Developments
Key Developments Mahad Unit – Operational Update On July 22nd, SHK temporarily suspended operations at its unit in Mahad on account of unprecedented rains, which caused severe flooding and major power outage in the area The Company has conducted a survey, wherein the total repair and damage cost
Slide 14: Key Developments
Key Developments Conducted vaccination drives for protection against Covid-19 for its employees, employee dependents, support staff and business partners Under its employee care initiative, SHK partnered with Apollo Hospital & other local hospitals for vaccination drives for protection against Cov
Slide 15: Financial and Operational Discussions (Y-o-Y)
Financial and Operational Discussions (Y-o-Y) Q1 FY22 Revenues from operations stood at Rs. 354.9 crore On a year-on-year basis, the Company’s performance is not comparable on account of consolidation of CFF and Nova in Q1 FY22 − On a like-to-like basis, revenues were higher by 44.4% owing to a lo
Slide 16: Fragrance Division
Fragrance Division The segment reported steady performance. Although operating constraints due to covid- induced disruptions impacted sequential growth, client engagements and wins across Particulars (Rs. crore) Q1 FY22 Q1 FY21 Y-o-Y (%) FMCG space remained stable during the quarter Revenues from
Slide 17: Flavour Division
Flavour Division On a year-over-year basis, revenues were higher on account of a lower base Sequentially, pandemic-induced operating Particulars (Rs. crore) Q1 FY22 Q1 FY21 Y-o-Y (%) constraints affected sales in the flavour division Revenues from Operations 24.3 14.9 62.8% Margins during the
Slide 18: CFF & Nova Performance
CFF & Nova Performance Abridged P&L Statement Quarter ending CFF & Nova delivered healthy performance Particulars as a % of Sales June 30, 2021 on the back of increasing demand and Sales – Core Fragrance 55.5 volume off-take in the European markets Sales – Contract Manufacturing 23.0 SHK anticip
Slide 19: Balance Sheet Snapshot – As on June 30, 2021
Balance Sheet Snapshot – As on June 30, 2021 386 1,033 806 92 0.4x Networth Net Debt* Fixed Assets Cash & Investments & Net Debt to Note: Equity 1) *Payment for acquisition of Nova in April 2021 coupled with slower collections due to lockdowns and restrictions in the domestic market led to a slight
Slide 20: Cash Flow Snapshot
Cash Flow Snapshot Particulars (Rs. crore) FY17 FY18 FY19 FY20 FY21 Q1FY22 Net Cash flows from operating activities 102 103 77 205 195 15 Net Cash flow from investing activities -96 -221 -137 -40 -149 -26 Net 6 -118 -60 165 46 -11 Note: Cash and cash equivalent includes investments in mutual fund No
Slide 21: Key Financial Ratios
Key Financial Ratios Particulars (Rs. crore) FY17 FY18 FY19 FY20 FY21 Q1FY22 EBITDA margin (%) 17.9 18.0 14.9 14.8 19.3 12.5 PAT Margin (%) 10.6 8.8 8.2 6.3 9.8 4.7 Debt to Equity 0.1 0.2 0.4 0.4 0.4 0.4 Return on Networth (%) 14.3 13.8 12.0 10.0 17.9 12.5 Adjusted Return on Networth* (%) 16.1 16.1
Slide 22: Annexure
Annexure 16
Slide 23: Conference Call Details
Conference Call Details S H Kelkar and Company – Q1 FY22 Earnings Conference Call Time • 2:00 PM IST on Monday, August 9, 2021 Primary dial-in number • +91 22 6280 1141 • +91 22 7115 8042 India Local access Number • +91 70456 71221 (Available all over India) • Hong Kong: 800 964 448 International To
Slide 24: About Us
About Us S H Kelkar and Company Limited (SHK) is the largest Indian-origin Fragrance & Flavour For further information please contact: Company in India. It has a long standing reputation in the fragrance industry developed in 96 years of experience. Its fragrance products and ingredients are used as
Slide 25: •
0 • 19
S H Kelkar and Company — Q1 FY2022 Earnings Presentation on 6ix